Literature DB >> 7895772

Identification of antagonists for melanocortin MC3, MC4 and MC5 receptors.

R A Adan1, J Oosterom, G Ludvigsdottir, J H Brakkee, J P Burbach, W H Gispen.   

Abstract

Antagonists for the melanocortin receptor family were identified by analysis of the effects of four melanocortin analogues on alpha-MSH(alpha-melanocyte-stimulating hormone)-induced cAMP accumulation in 293 human embryonal kidney (HEK) cells that expressed either the rat melanocortin MC3 receptor, the human melanocortin MC4 receptor or the ovine melanocortin MC5 receptor. Two peptides, [D-Arg8]ACTH(adrenocorticotrope hormone)-(4-10) and [Pro8,10,Gly9]ACTH-(4-10), antagonized the action of alpha-MSH on the melanocortin MC4 and MC5 receptors, but not the melanocortin MC3 receptor. [Ala6]ACTH-(4-10) inhibited the alpha-MSH activation of the melanocortin MC3 and MC5, but only weakly antagonized the activation of the melanocortin MC4 receptor. [Phe-I7]ACTH-(4-10) antagonized the melanocortin MC3, MC4 and MC5 receptors equally well. These antagonists were also tested to block a behavioral response induced by alpha-MSH. alpha-MSH-induced excessive grooming behavior in rats was inhibited by [Phe-I7]ACTH-(4-10), [D-Arg8]ACTH-(4-10) and [Pro8,10,Gly9]ACTH-(4-10), but not by [Ala6]ACTH-(4-10). This suggests that alpha-MSH-induced excessive grooming behavior is mediated by melanocortin MC4 receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7895772     DOI: 10.1016/0922-4106(94)90041-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Effects of Semax on dopaminergic and serotoninergic systems of the brain.

Authors:  K O Eremin; V S Kudrin; I A Grivennikov; N F Miasoedov; K S Rayevsky
Journal:  Dokl Biol Sci       Date:  2004 Jan-Feb

2.  Effect of Semax on changes in pain sensitivity and behavior of animals induced by forced swimming.

Authors:  D M Ivanova; D A Vilenskiĭ; N G Levitskaya; L A Andreeva; L Yu Alfeeva; A A Kamenskiĭ; N F Miasoedov
Journal:  Dokl Biol Sci       Date:  2006 Mar-Apr

3.  Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents.

Authors:  Kirill O Eremin; Vladimir S Kudrin; Pirjo Saransaari; Simo S Oja; Igor A Grivennikov; Nikolay F Myasoedov; Kirill S Rayevsky
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

4.  Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist.

Authors:  G V Skuladottir; L Jonsson; J O Skarphedinsson; F Mutulis; R Muceniece; A Raine; I Mutule; J Helgason; P Prusis; J E Wikberg; H B Schiöth
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

Review 5.  Can neuropeptides treat obesity? A review of neuropeptides and their potential role in the treatment of obesity.

Authors:  C K Boughton; K G Murphy
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

6.  Novel Insights into the Protective Properties of ACTH(4-7)PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia-Reperfusion in Rats.

Authors:  Ivan B Filippenkov; Vasily V Stavchansky; Alina E Denisova; Vadim V Yuzhakov; Larisa E Sevan'kaeva; Olga Y Sudarkina; Veronika G Dmitrieva; Leonid V Gubsky; Nikolai F Myasoedov; Svetlana A Limborska; Lyudmila V Dergunova
Journal:  Genes (Basel)       Date:  2020-06-22       Impact factor: 4.096

7.  Curbing Inflammation through Endogenous Pathways: Focus on Melanocortin Peptides.

Authors:  Tazeen J Ahmed; Trinidad Montero-Melendez; Mauro Perretti; Costantino Pitzalis
Journal:  Int J Inflam       Date:  2013-05-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.